Abstract:Reductions in hydrogen sulfide (H2S) production have been implicated in the pathogenesis of hypertension; however, no studies have examined the functional role of hydrogen sulfide in hypertensive heart disease. We hypothesized that the endogenous production of hydrogen sulfide would be reduced and exogenous hydrogen sulfide would ameliorate cardiac dysfunction in Nω-nitro- L-arginine methyl ester ( L-NAME)-induced hypertensive rats. Therefore, this study investigated the cardioprotective effects of hydrogen sulfide on L-NAME-induced hypertensive heart disease and explored potential mechanisms. The rats were randomly divided into five groups: Control, Control + sodium hydrosulfide (NaHS), L-NAME, L-NAME + NaHS, and L-NAME + NaHS + glibenclamide (Gli) groups. Systolic blood pressure was monitored each week. In Langendorff-isolated rat heart, cardiac function represented by ±LV dP/dtmax and left ventricular developing pressure was recorded after five weeks of treatment. Hematoxylin and Eosin and Masson's trichrome staining and myocardium ultrastructure under transmission electron microscopy were used to evaluate cardiac remodeling. The plasma nitric oxide and hydrogen sulfide concentrations, as well as nitric oxide synthases and cystathionine-γ-lyase activity in left ventricle tissue were determined. The protein expression of p-Akt, Akt, p-eNOS, and eNOS in left ventricle tissue was analyzed using Western blot. After five weeks of L-NAME treatment, there was a time-dependent hypertension, cardiac remodeling, and dysfunction accompanied by a decrease in eNOS phosphorylation, nitric oxide synthase activity, and nitric oxide concentration. Meanwhile, cystathionine-γ-lyase activity and hydrogen sulfide concentration were also decreased. NaHS treatment significantly increased plasma hydrogen sulfide concentration and subsequently promoted the Akt/eNOS/NO pathway which inhibited the development of hypertension and attenuated cardiac remodeling and dysfunction. The cardioprotective effects of NaHS were counteracted by Gli which inhibited the Akt/eNOS/NO pathway. This suggests that the effects of hydrogen sulfide were mediated by the activation of the KATP channels. In conclusion, hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease via the activation of the Akt/eNOS/NO pathway, which was mediated by KATP channels. Impact statement 1. We found that H2S ameliorated L-NAME-induced cardiac remodeling and dysfunction, and played a protective role in L-NAME-induced hypertensive heart disease, which the existing studies have not reported. 2. H2S activated the Akt/eNOS/NO pathway, thereby playing a cardioprotective role in L-NAME-induced hypertensive heart disease. 3. The cardioprotective effect of H2S was mediated by ATP-sensitive potassium channels.

Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats

Sodium Hydrosulfide Improves Cardiac Functions and Structures in Rats with Chronic Heart Failure

Hydrogen Sulfide Improves Myocardial Remodeling Via Downregulated Angiotensin Ⅱ/AT1R Pathway in Renovascular Hypertensive Rats.

Hydrogen Sulfide Alleviates Myocardial Collagen Remodeling in Association with Inhibition of TGF-β/Smad Signaling Pathway in Spontaneously Hypertensive Rats

Sodium Hydrosulfide Prevents Myocardial Dysfunction Through Modulation of Extracellular Matrix Accumulation and Vascular Density

Possible Effects of Endogenous Hydrogen Sulfide on Aortic Remodeling in Hypertensive Rats

Regulatory Effect of Hydrogen Sulfide on Vascular Collagen Content in Spontaneously Hypertensive Rats

Hydrogen Sulfide Improves Endothelial Dysfunction in Hypertension by Activating Peroxisome Proliferator-Activated Receptor Delta/endothelial Nitric Oxide Synthase Signaling.

Hydrogen Sulfide Attenuates Cardiac Dysfunction in a Rat Model of Heart Failure: a Mechanism Through Cardiac Mitochondrial Protection

Hydrogen Sulfide Ameliorated L-NAME-induced Hypertensive Heart Disease by the Akt/eNOS/NO Pathway

[Effects of Hydrogen Sulfide Donor on Production of Adrenomedullin and Atrial Natriuretic Peptide in Rats with Atherosclerosis].

Inhibition of NADPH Oxidase 4-Related Signaling by Sodium Hydrosulfide Attenuates Myocardial Fibrotic Response.

[Hypotensive Effects of Hydrogen Sulfide Via Attenuating Vascular Inflammation in Spontaneously Hypertensive Rats].

Central cardiovascular effect of hydrogen sulfide and its possible mechanism

Hydrogen Sulfide Improves Endothelial Dysfunction Via Downregulating BMP4/COX-2 Pathway in Rats with Hypertension.

Sodium Hydrosulfide Alleviates Pulmonary Artery Collagen Remodeling in Rats with High Pulmonary Blood Flow

Hydrogen Sulfide Inhibits High-Salt Diet-Induced Myocardial Oxidative Stress and Myocardial Hypertrophy in Dahl Rats.

Exogenous Hydrogen Sulphide Ameliorates Diabetic Cardiomyopathy in Rats by Reversing Disordered Calcium-Handling System in Sarcoplasmic Reticulum

Hydrogen Sulfide Alleviate Accumulation of Collagen in Aorta of Spontaneous Hypertensive Rats

[Changes and Significance of Hydrogen Sulfide/cystathionine Gamma-Lyase System in Hypertension: an Experimental Study with Rats].

Exogenous Hydrogen Sulfide Alleviated Left Ventricular Fibrosis Via Enhancing Cardiac Autophagy and Decreasing Cardiomyocyte Apoptosis in StreptozotocinInduced Diabetic Rats: From Network Pharmacology to Experimental Pharmacology